Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Objectives: To investigate whether CT-based radiomics signature can predict KRAS/NRAS/BRAF mutations in colorectal cancer (CRC).Methods: This retrospective study consisted of a primary cohort (n = 61) and a validation cohort (n = 56) with pathologically confirmed CRC. Patients underwent KRAS/NRAS/BR...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 28; no. 5; pp. 2058 - 2068
Autores principales: Yang, Lei, Dong, Di, Fang, Mengjie, Zhu, Yongbei, Zang, Yali, Liu, Zhenyu, Zhang, Hongmei, Ying, Jianming, Zhao, Xinming, Tian, Jie
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature May2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128864681&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128864681
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: May2018
      vid: 28
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        128864681
        128864681
        NLM29335867
        128864681
        10.1007/s00330-017-5146-8
        NLM29335867
        128864681
      ppf: 2058
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
      aug:
        au:
          Yang, Lei
          Dong, Di
          Fang, Mengjie
          Zhu, Yongbei
          Zang, Yali
          Liu, Zhenyu
          Zhang, Hongmei
          Ying, Jianming
          Zhao, Xinming
          Tian, Jie
        affil: Department of Diagnostic Radiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, PO Box 2258, No. 17, Pan Jia Yuan Nan-li, 100021, Beijing, China
      sug:
        subj:
          Transferases
          Proteins
          Hydrolases
          Colorectal Neoplasms
          Tomography, X-Ray Computed Methods
          Mutation
          Membrane Proteins
          Retrospective Design
          Male
          Female
          Sensitivity and Specificity
          Neoplasm Staging
          Contrast Media
          Aged
          Middle Age
          Colon
          Radiographic Image Enhancement
          Adult
          Predictive Value of Tests
          Human
          Funding Source
          Aged: 65+ years
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Male
          Female
      ab: Objectives: To investigate whether CT-based radiomics signature can predict KRAS/NRAS/BRAF mutations in colorectal cancer (CRC).Methods: This retrospective study consisted of a primary cohort (n = 61) and a validation cohort (n = 56) with pathologically confirmed CRC. Patients underwent KRAS/NRAS/BRAF mutation tests and contrast-enhanced CT before treatment. A total of 346 radiomics features were extracted from portal venous-phase CT images of the entire primary tumour. Associations between the genetic mutations and clinical background, tumour staging, and histological differentiation were assessed using univariate analysis. RELIEFF and support vector machine methods were performed to select key features and build a radiomics signature.Results: The radiomics signature was significantly associated with KRAS/NRAS/BRAF mutations (P < 0.001). The area under the curve, sensitivity, and specificity for predicting KRAS/NRAS/BRAF mutations were 0.869, 0.757, and 0.833 in the primary cohort, respectively, while they were 0.829, 0.686, and 0.857 in the validation cohort, respectively. Clinical background, tumour staging, and histological differentiation were not associated with KRAS/NRAS/BRAF mutations in both cohorts (P>0.05).Conclusions: The proposed CT-based radiomics signature is associated with KRAS/NRAS/BRAF mutations. CT may be useful for analysis of tumour genotype in CRC and thus helpful to determine therapeutic strategies.Key Points: • Key features were extracted from CT images of the primary colorectal tumour. • The proposed radiomics signature was significantly associated with KRAS/NRAS/BRAF mutations. • In the primary cohort, the proposed radiomics signature predicted mutations. • Clinical background, tumour staging, and histological differentiation were unable to predict mutations.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N